| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 3.23e-15 | 37 | 105 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 4.36e-15 | 38 | 105 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.32e-07 | 11 | 105 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 6.94e-07 | 14 | 105 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 DHX58 MYCBP2 ENPP1 ENPP2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZFP37 ZBBX ZDHHC15 SLFN13 ERVK-8 ERVK-19 ERVK-24 TET3 SOD1 | 8.52e-07 | 891 | 105 | 18 | GO:0008270 |
| GeneOntologyMolecularFunction | phosphodiesterase I activity | 1.40e-06 | 5 | 105 | 3 | GO:0004528 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAMTS12 ADGB ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.73e-06 | 430 | 105 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.03e-06 | 21 | 105 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 4.22e-06 | 46 | 105 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 DHX58 MYCBP2 ENPP1 ENPP2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZFP37 ZBBX ZDHHC15 SLFN13 AGMO ERVK-8 ERVK-19 ERVK-24 TET3 SOD1 | 1.25e-05 | 1189 | 105 | 19 | GO:0046914 |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 2.74e-05 | 2 | 105 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.02e-05 | 231 | 105 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 DHX58 THUMPD3 ERVK-7 ERVK-10 RFC4 FAN1 DDX46 SLFN13 MOV10L1 ERVK-8 DDX23 TOP3B | 3.37e-05 | 645 | 105 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 NAALAD2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAMTS12 ADGB ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 3.89e-05 | 654 | 105 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 4.17e-05 | 37 | 105 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.64e-05 | 38 | 105 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 6.04e-05 | 79 | 105 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 RPL35A RPS4X ERVK-7 ERVK-21 ERVK-9 ERVK-10 NEB HMCN1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 VCL | 6.42e-05 | 891 | 105 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 DHX58 THUMPD3 ERVK-7 ERVK-10 DDX46 SLFN13 MOV10L1 ERVK-8 DDX23 | 6.99e-05 | 417 | 105 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | Pyrin domain binding | 8.19e-05 | 3 | 105 | 2 | GO:0032090 | |
| GeneOntologyMolecularFunction | endonuclease activity | 8.28e-05 | 136 | 105 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 1.63e-04 | 4 | 105 | 2 | GO:0047655 | |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 2.71e-04 | 5 | 105 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.95e-04 | 321 | 105 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.71e-04 | 262 | 105 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.30e-04 | 360 | 105 | 8 | GO:0051020 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.62e-04 | 136 | 105 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 7.64e-04 | 78 | 105 | 4 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 8.40e-04 | 80 | 105 | 4 | GO:0008186 | |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 9.63e-04 | 9 | 105 | 2 | GO:0004551 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase inhibitor activity | 9.63e-04 | 9 | 105 | 2 | GO:0019828 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.05e-03 | 85 | 105 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | helicase activity | 1.49e-03 | 158 | 105 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DHX58 ENPP1 ENPP2 TOR1A SRP54 RFC4 DDX46 SLFN13 MOV10L1 ARL13B DDX23 AGAP2 | 1.52e-03 | 839 | 105 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DHX58 ENPP1 ENPP2 TOR1A SRP54 RFC4 DDX46 SLFN13 MOV10L1 ARL13B DDX23 AGAP2 | 1.53e-03 | 840 | 105 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DHX58 ENPP1 ENPP2 TOR1A SRP54 RFC4 DDX46 SLFN13 MOV10L1 ARL13B DDX23 AGAP2 | 1.53e-03 | 840 | 105 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | interleukin-1 binding | 1.75e-03 | 12 | 105 | 2 | GO:0019966 | |
| GeneOntologyMolecularFunction | phospholipase inhibitor activity | 2.06e-03 | 13 | 105 | 2 | GO:0004859 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.29e-03 | 441 | 105 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 2.39e-03 | 14 | 105 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | protease binding | 2.69e-03 | 181 | 105 | 5 | GO:0002020 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 2.75e-03 | 15 | 105 | 2 | GO:0051011 | |
| GeneOntologyMolecularFunction | S100 protein binding | 2.75e-03 | 15 | 105 | 2 | GO:0044548 | |
| GeneOntologyMolecularFunction | caspase binding | 3.13e-03 | 16 | 105 | 2 | GO:0089720 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.13e-03 | 16 | 105 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipase inhibitor activity | 3.97e-03 | 18 | 105 | 2 | GO:0055102 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.08e-03 | 614 | 105 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.39e-03 | 21 | 105 | 2 | GO:0030228 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.89e-07 | 13 | 102 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis involved in cholesterol transport | 1.88e-05 | 11 | 102 | 3 | GO:0090118 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 2.42e-05 | 2 | 102 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 6.42e-05 | 85 | 102 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 6.42e-05 | 85 | 102 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 7.24e-05 | 3 | 102 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 7.24e-05 | 3 | 102 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | syncytium formation | 8.00e-05 | 89 | 102 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 9.28e-05 | 48 | 102 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ADAR LDLR ERVK-8 ERVK-19 ERVK-24 | 1.01e-04 | 464 | 102 | 10 | GO:0016032 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 1.44e-04 | 4 | 102 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 1.44e-04 | 4 | 102 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 1.44e-04 | 4 | 102 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 1.44e-04 | 4 | 102 | 2 | GO:0032382 | |
| GeneOntologyBiologicalProcess | regulation of receptor binding | 2.20e-04 | 24 | 102 | 3 | GO:1900120 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle clearance | 2.20e-04 | 24 | 102 | 3 | GO:0010988 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane repair | 2.40e-04 | 5 | 102 | 2 | GO:1905686 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.40e-04 | 5 | 102 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor binding | 2.40e-04 | 5 | 102 | 2 | GO:1905595 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular lipid transport | 2.40e-04 | 5 | 102 | 2 | GO:0032379 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.58e-04 | 178 | 102 | 6 | GO:0006261 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein receptor activity | 3.59e-04 | 6 | 102 | 2 | GO:1905599 | |
| GeneOntologyBiologicalProcess | regulation of receptor recycling | 4.77e-04 | 31 | 102 | 3 | GO:0001919 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 5.00e-04 | 7 | 102 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 5.00e-04 | 7 | 102 | 2 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 5.00e-04 | 7 | 102 | 2 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 5.00e-04 | 7 | 102 | 2 | GO:0032799 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 EVL MYCBP2 ENPP1 CAMSAP3 TOR1A ZDHHC15 PTPRF PTPRS CNTN5 LRP2 PRDM12 CAMSAP2 ALK VCL SOD1 | 5.53e-04 | 1285 | 102 | 16 | GO:0031175 |
| GeneOntologyCellularComponent | actomyosin | 2.48e-05 | 117 | 103 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 7.19e-05 | 3 | 103 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 7.19e-05 | 3 | 103 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 4.97e-04 | 7 | 103 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | microtubule minus-end | 4.97e-04 | 7 | 103 | 2 | GO:0036449 | |
| Domain | P-loop_NTPase | TANC2 TPST1 DHX58 NLRP7 APAF1 TOR1A SRP54 RFC4 NLRP2 DDX46 SLFN13 MOV10L1 ARL13B DDX23 AGAP2 | 1.20e-05 | 848 | 90 | 15 | IPR027417 |
| Domain | - | TPST1 DHX58 NLRP7 APAF1 TOR1A SRP54 RFC4 NLRP2 DDX46 SLFN13 MOV10L1 ARL13B DDX23 AGAP2 | 1.26e-05 | 746 | 90 | 14 | 3.40.50.300 |
| Domain | KELK | 2.30e-05 | 2 | 90 | 2 | IPR031597 | |
| Domain | KELK | 2.30e-05 | 2 | 90 | 2 | PF15796 | |
| Domain | CAMSAP_CC1 | 6.87e-05 | 3 | 90 | 2 | PF17095 | |
| Domain | CAMSAP_CKK | 6.87e-05 | 3 | 90 | 2 | SM01051 | |
| Domain | PRC_barrel-like | 6.87e-05 | 3 | 90 | 2 | IPR011033 | |
| Domain | CKK_domain | 6.87e-05 | 3 | 90 | 2 | IPR014797 | |
| Domain | CAMSAP_CKK | 6.87e-05 | 3 | 90 | 2 | PF08683 | |
| Domain | CAMSAP_CC1 | 6.87e-05 | 3 | 90 | 2 | IPR031372 | |
| Domain | CAMSAP | 6.87e-05 | 3 | 90 | 2 | IPR032940 | |
| Domain | CKK | 6.87e-05 | 3 | 90 | 2 | PS51508 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.37e-04 | 4 | 90 | 2 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.37e-04 | 4 | 90 | 2 | PD011252 | |
| Domain | DMPK_coil | 1.37e-04 | 4 | 90 | 2 | PF08826 | |
| Domain | PWI | 2.27e-04 | 5 | 90 | 2 | PF01480 | |
| Domain | - | 2.27e-04 | 5 | 90 | 2 | 1.20.1390.10 | |
| Domain | Somatomedin_B_chordata | 2.27e-04 | 5 | 90 | 2 | IPR020436 | |
| Domain | PWI_dom | 2.27e-04 | 5 | 90 | 2 | IPR002483 | |
| Domain | DNA/RNA_non-sp_Endonuclease | 3.40e-04 | 6 | 90 | 2 | IPR001604 | |
| Domain | - | 3.40e-04 | 6 | 90 | 2 | 3.40.570.10 | |
| Domain | Endonuclease_NS | 3.40e-04 | 6 | 90 | 2 | PF01223 | |
| Domain | Extracellular_endonuc_su_A | 3.40e-04 | 6 | 90 | 2 | IPR020821 | |
| Domain | NUC | 3.40e-04 | 6 | 90 | 2 | SM00477 | |
| Domain | Endonuclease_NS | 3.40e-04 | 6 | 90 | 2 | SM00892 | |
| Domain | CAMSAP_CH | 4.75e-04 | 7 | 90 | 2 | PF11971 | |
| Domain | E-NPP | 4.75e-04 | 7 | 90 | 2 | IPR024873 | |
| Domain | Epimerase_deHydtase | 4.75e-04 | 7 | 90 | 2 | IPR001509 | |
| Domain | CAMSAP_CH | 4.75e-04 | 7 | 90 | 2 | IPR022613 | |
| Domain | Epimerase | 4.75e-04 | 7 | 90 | 2 | PF01370 | |
| Domain | Somatomedin_B | 6.31e-04 | 8 | 90 | 2 | PF01033 | |
| Domain | SO | 8.09e-04 | 9 | 90 | 2 | SM00201 | |
| Domain | Somatomedin_B_dom | 1.01e-03 | 10 | 90 | 2 | IPR001212 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.01e-03 | 10 | 90 | 2 | PS00798 | |
| Domain | SMB_1 | 1.01e-03 | 10 | 90 | 2 | PS00524 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.01e-03 | 10 | 90 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.01e-03 | 10 | 90 | 2 | PS00063 | |
| Domain | Phosphodiest/P_Trfase | 1.01e-03 | 10 | 90 | 2 | IPR002591 | |
| Domain | SMB_2 | 1.01e-03 | 10 | 90 | 2 | PS50958 | |
| Domain | Aldo/ket_reductase_CS | 1.01e-03 | 10 | 90 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.01e-03 | 10 | 90 | 2 | IPR020471 | |
| Domain | Phosphodiest | 1.01e-03 | 10 | 90 | 2 | PF01663 | |
| Domain | Filamin | 1.23e-03 | 11 | 90 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.23e-03 | 11 | 90 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.23e-03 | 11 | 90 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.23e-03 | 11 | 90 | 2 | IPR017868 | |
| Domain | - | 1.41e-03 | 46 | 90 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.60e-03 | 48 | 90 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.70e-03 | 49 | 90 | 3 | IPR002172 | |
| Domain | LDLa | 1.70e-03 | 49 | 90 | 3 | SM00192 | |
| Domain | LDLRA_2 | 1.70e-03 | 49 | 90 | 3 | PS50068 | |
| Domain | Ldl_recept_b | 2.01e-03 | 14 | 90 | 2 | PF00058 | |
| Domain | LDLRB | 2.01e-03 | 14 | 90 | 2 | PS51120 | |
| Domain | CNH | 2.01e-03 | 14 | 90 | 2 | SM00036 | |
| Domain | Ig_I-set | 2.26e-03 | 190 | 90 | 5 | IPR013098 | |
| Domain | I-set | 2.26e-03 | 190 | 90 | 5 | PF07679 | |
| Domain | LY | 2.31e-03 | 15 | 90 | 2 | SM00135 | |
| Domain | CNH | 2.31e-03 | 15 | 90 | 2 | PF00780 | |
| Domain | CNH | 2.31e-03 | 15 | 90 | 2 | PS50219 | |
| Domain | CNH_dom | 2.31e-03 | 15 | 90 | 2 | IPR001180 | |
| Domain | LDLR_classB_rpt | 2.31e-03 | 15 | 90 | 2 | IPR000033 | |
| Domain | - | 2.64e-03 | 16 | 90 | 2 | 3.20.20.100 | |
| Domain | PBD | 2.64e-03 | 16 | 90 | 2 | SM00285 | |
| Domain | NADP_OxRdtase_dom | 2.98e-03 | 17 | 90 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 2.98e-03 | 17 | 90 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 2.98e-03 | 17 | 90 | 2 | IPR001395 | |
| Domain | RCC1 | 4.12e-03 | 20 | 90 | 2 | PF00415 | |
| Domain | CRIB | 4.12e-03 | 20 | 90 | 2 | PS50108 | |
| Domain | RCC1_1 | 4.54e-03 | 21 | 90 | 2 | PS00625 | |
| Domain | RCC1_2 | 4.54e-03 | 21 | 90 | 2 | PS00626 | |
| Domain | RCC1_3 | 4.54e-03 | 21 | 90 | 2 | PS50012 | |
| Domain | CRIB_dom | 4.54e-03 | 21 | 90 | 2 | IPR000095 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.63e-13 | 5 | 108 | 5 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 3.96e-13 | 94 | 108 | 10 | 21542922 |
| Pubmed | 1.40e-11 | 18 | 108 | 6 | 18664271 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 8.79e-11 | 4 | 108 | 4 | 10469592 | |
| Pubmed | 2.05e-10 | 12 | 108 | 5 | 14557543 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 10516026 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 CRYBG2 CDC42BPA MYCBP2 DOCK9 CDC42BPB LDLR C6orf132 PPP1R26 KMT2D PTPRF PTPRS TTLL4 HPS6 HMGXB3 MBD5 TOP3B | 5.51e-08 | 1105 | 108 | 17 | 35748872 |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 38481805 | ||
| Pubmed | Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation. | 1.16e-07 | 4 | 108 | 3 | 22848640 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 7983737 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 18799458 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL35A MYCBP2 ACAT2 ANXA2 RPS4X RBM26 CAMSAP3 AKR1A1 RFC4 ADAR NEK9 DDX46 RBM27 PRDX1 VCL SOD1 | 5.34e-07 | 1149 | 108 | 16 | 35446349 |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 15063128 | ||
| Pubmed | MYCBP2 ANXA2 RBM26 ADAR NEK9 GTF2F2 KMT2D DDX46 RBM27 PRDX1 VCL | 1.19e-06 | 549 | 108 | 11 | 38280479 | |
| Pubmed | 1.23e-06 | 340 | 108 | 9 | 24332808 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RBM26 SRP54 PRPF38B RFC4 ADAR NEK9 GTF2F2 DDX46 RBM27 PRDX1 CAMSAP2 VCL SOD1 KNL1 | 1.24e-06 | 934 | 108 | 14 | 33916271 |
| Pubmed | TANC2 EVL RPL35A ANXA2 RPS4X ANXA2P2 CAMSAP3 NDUFA9 CDC42BPB GJA3 PTPRS AKR1B10 PRDX1 CAMSAP2 VCL SOD1 AGAP2 | 2.01e-06 | 1431 | 108 | 17 | 37142655 | |
| Pubmed | TANC2 EVL CDC42BPA MYCBP2 ANXA2 RPS4X ANXA2P2 DOCK9 CAMSAP3 PRPF38B NDUFA9 CDC42BPB PRDX1 CAMSAP2 AGAP2 | 2.48e-06 | 1139 | 108 | 15 | 36417873 | |
| Pubmed | 3.44e-06 | 10 | 108 | 3 | 12970426 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27881734 | ||
| Pubmed | CAMSAP3 maintains neuronal polarity through regulation of microtubule stability. | 9.55e-06 | 2 | 108 | 2 | 30190432 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19536308 | ||
| Pubmed | Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. | 9.55e-06 | 2 | 108 | 2 | 21076462 | |
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 9.55e-06 | 2 | 108 | 2 | 23148505 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37567766 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 33090377 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38290972 | ||
| Pubmed | Cloning and chromosomal localization of human Cdc42-binding protein kinase beta. | 9.55e-06 | 2 | 108 | 2 | 10198171 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 3013423 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 35064931 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 9.55e-06 | 2 | 108 | 2 | 28130864 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17549680 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 39384746 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20826156 | ||
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 9.55e-06 | 2 | 108 | 2 | 27468426 | |
| Pubmed | Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. | 9.55e-06 | 2 | 108 | 2 | 16127462 | |
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 9.55e-06 | 2 | 108 | 2 | 19841537 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27389701 | ||
| Pubmed | Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. | 9.55e-06 | 2 | 108 | 2 | 21240269 | |
| Pubmed | A family of RS domain proteins with novel subcellular localization and trafficking. | 9.55e-06 | 2 | 108 | 2 | 15741184 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17360942 | ||
| Pubmed | Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina. | 9.55e-06 | 2 | 108 | 2 | 19587120 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 18263588 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19022301 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30454891 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38253182 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23169647 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16046141 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31162334 | ||
| Pubmed | Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis. | 9.55e-06 | 2 | 108 | 2 | 22185818 | |
| Pubmed | Primary cilia are specialized calcium signalling organelles. | 9.55e-06 | 2 | 108 | 2 | 24336288 | |
| Pubmed | A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. | 9.55e-06 | 2 | 108 | 2 | 21486955 | |
| Pubmed | NLRP2 is highly expressed in a mouse model of ischemic stroke. | 9.55e-06 | 2 | 108 | 2 | 27693696 | |
| Pubmed | Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2. | 9.55e-06 | 2 | 108 | 2 | 21737841 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19580511 | ||
| Pubmed | VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? | 9.55e-06 | 2 | 108 | 2 | 24698962 | |
| Pubmed | A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage. | 9.55e-06 | 2 | 108 | 2 | 23360675 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9060628 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 36739096 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 9.55e-06 | 2 | 108 | 2 | 9460924 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22517898 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30462534 | ||
| Pubmed | Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis. | 9.55e-06 | 2 | 108 | 2 | 38092984 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21572519 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21788340 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 27371724 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31817350 | ||
| Pubmed | Nlrp2, a maternal effect gene required for early embryonic development in the mouse. | 9.55e-06 | 2 | 108 | 2 | 22295082 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 37832154 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30902828 | ||
| Pubmed | Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis. | 9.55e-06 | 2 | 108 | 2 | 24742684 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32687500 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 38582229 | ||
| Pubmed | Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris. | 9.55e-06 | 2 | 108 | 2 | 22453828 | |
| Pubmed | Agents that bind annexin A2 suppress ocular neovascularization. | 9.55e-06 | 2 | 108 | 2 | 20607799 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 32482850 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15096095 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31253864 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 9.55e-06 | 2 | 108 | 2 | 11672541 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 19628708 | ||
| Pubmed | Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA. | 9.55e-06 | 2 | 108 | 2 | 15654879 | |
| Pubmed | Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. | 9.55e-06 | 2 | 108 | 2 | 20847146 | |
| Pubmed | SRF phosphorylation by glycogen synthase kinase-3 promotes axon growth in hippocampal neurons. | 1.29e-05 | 15 | 108 | 3 | 24623780 | |
| Pubmed | MACC1 RPL35A CDC42BPA RBM26 CAMSAP3 SRP54 PRPF38B NDUFA9 YES1 CDC42BPB C6orf132 GTF2F2 DDX46 RBM27 MCRS1 CAMSAP2 | 1.55e-05 | 1497 | 108 | 16 | 31527615 | |
| Pubmed | 1.58e-05 | 170 | 108 | 6 | 15057823 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 1.95e-05 | 264 | 108 | 7 | 32814769 | |
| Pubmed | CDC42BPA ANXA2 SELENOH RBM26 SRP54 PRPF38B RFC4 CDC42BPB DDX46 RBM27 AKR1B10 DDX23 NKTR ALK SOD1 | 2.25e-05 | 1371 | 108 | 15 | 36244648 | |
| Pubmed | 2.30e-05 | 18 | 108 | 3 | 21518694 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35098646 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 22909446 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 36976514 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 35413401 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 28694388 | ||
| Pubmed | High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2. | 2.86e-05 | 3 | 108 | 2 | 27470587 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 29574422 | ||
| Pubmed | Annexins--unique membrane binding proteins with diverse functions. | 2.86e-05 | 3 | 108 | 2 | 15169834 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 24808179 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.86e-05 | 3 | 108 | 2 | 31985401 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26963384 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20139422 | ||
| Interaction | ARHGEF2 interactions | EVL CDC42BPA MYCBP2 SELENOH SRP54 PTPRF PRDX1 CAMSAP2 TOP3B ALK VCL | 5.86e-08 | 256 | 100 | 11 | int:ARHGEF2 |
| Interaction | BAP1 interactions | RPL35A MYCBP2 ACAT2 ANXA2 RPS4X RBM26 CAMSAP3 AKR1A1 RFC4 ADAR NEK9 DDX46 RBM27 ALDH1L2 DHODH PRDX1 MCRS1 MBD5 TOP3B VCL SOD1 | 1.52e-06 | 1314 | 100 | 21 | int:BAP1 |
| Interaction | LINC02910 interactions | 7.81e-06 | 95 | 100 | 6 | int:LINC02910 | |
| Interaction | IGFL3 interactions | 3.57e-05 | 75 | 100 | 5 | int:IGFL3 | |
| Interaction | SETD1B interactions | 3.57e-05 | 75 | 100 | 5 | int:SETD1B | |
| Interaction | ANAPC15 interactions | 4.27e-05 | 128 | 100 | 6 | int:ANAPC15 | |
| Interaction | PSENEN interactions | 5.17e-05 | 81 | 100 | 5 | int:PSENEN | |
| Cytoband | 12q13.12 | 9.78e-05 | 38 | 107 | 3 | 12q13.12 | |
| Cytoband | 11q22.1 | 4.81e-04 | 14 | 107 | 2 | 11q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p21 | 1.21e-03 | 89 | 107 | 3 | chr7p21 | |
| Cytoband | 12q14.1 | 1.96e-03 | 28 | 107 | 2 | 12q14.1 | |
| GeneFamily | Low density lipoprotein receptors | 9.97e-04 | 13 | 66 | 2 | 634 | |
| GeneFamily | Aldo-keto reductases | 1.34e-03 | 15 | 66 | 2 | 399 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.64e-03 | 21 | 66 | 2 | 813 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.84e-03 | 161 | 66 | 4 | 593 | |
| GeneFamily | NLR family | 3.73e-03 | 25 | 66 | 2 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 3.73e-03 | 25 | 66 | 2 | 994 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.32e-03 | 181 | 66 | 4 | 694 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING | 1.30e-05 | 82 | 96 | 5 | MM3777 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE | 1.63e-05 | 86 | 96 | 5 | MM1209 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-07 | 195 | 98 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-06 | 169 | 98 | 6 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 2.66e-06 | 177 | 98 | 6 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.32e-06 | 184 | 98 | 6 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_DC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.76e-06 | 188 | 98 | 6 | 08eb1e4b719af53c52895557523d0a1b7421d849 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 4.37e-06 | 193 | 98 | 6 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.36e-06 | 200 | 98 | 6 | 6a76c8e3d937a9c54eb81cab23b8a898f9600de1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-05 | 173 | 98 | 5 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-05 | 173 | 98 | 5 | 34357f0e22c4b6d84582492c82c1ea733ca8477d | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-05 | 175 | 98 | 5 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-05 | 177 | 98 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.13e-05 | 182 | 98 | 5 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-05 | 185 | 98 | 5 | 8b381706b656d366b63adb9703db1c3dc796b3f8 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-05 | 186 | 98 | 5 | adba5647a2feaba8e361dc1020d2f2dc4ce36b16 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.69e-05 | 186 | 98 | 5 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.84e-05 | 187 | 98 | 5 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.30e-05 | 190 | 98 | 5 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.30e-05 | 190 | 98 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 192 | 98 | 5 | 7ccdb977320d09f21e70e7718ead73eeb56d0c48 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 192 | 98 | 5 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 192 | 98 | 5 | bfc68af68fdb99ddfe4add49671e4b4c26e6f962 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | 63205026e20cf2c7bfb7d08bba48d5df7976ccca | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.95e-05 | 194 | 98 | 5 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | MS-CD4-memory_CD4|MS / Condition, Cell_class and T cell subcluster | 7.12e-05 | 195 | 98 | 5 | 41ef1304800eda995df88c6057e9835ea31e9125 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 195 | 98 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | severe-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.12e-05 | 195 | 98 | 5 | 5badcfdeed2fb7453a9c144506ca91c5475cd35f | |
| ToppCell | CTRL|World / Disease state, Lineage and Cell class | 7.12e-05 | 195 | 98 | 5 | cad77cdc6e0aa0875eff5ecd3805a6cf056d729d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.12e-05 | 195 | 98 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-05 | 197 | 98 | 5 | 8623972c7a70b3565b7a3a4afe93f1e012008201 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Monocyte-derived_DC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.47e-05 | 197 | 98 | 5 | 97b73eb1f9e655b7d9f616880b3756ffd5a44c64 | |
| ToppCell | control-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.47e-05 | 197 | 98 | 5 | cdb2866d5a8fbf39847309124479ad49c88852d4 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.47e-05 | 197 | 98 | 5 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.65e-05 | 198 | 98 | 5 | cb8f099cf4ed320615b1c60ddab86b89d8db9a43 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 7.65e-05 | 198 | 98 | 5 | 23783572c22c24d9fb8e14dc1f3852d2094157df | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-05 | 198 | 98 | 5 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | mild-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.65e-05 | 198 | 98 | 5 | ba97ff6e9d400b53ad013dce54afd7154a0f4fc9 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.65e-05 | 198 | 98 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | kidney_cells|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 198 | 98 | 5 | 13f74660bc571312355446e78891931b1295d720 | |
| ToppCell | NS-moderate|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.65e-05 | 198 | 98 | 5 | 47dd7f6bc5f2e989104759fd0b0e0b71baa85453 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 198 | 98 | 5 | df681a2308bf75f4d3cef05d7418aabc96116880 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.83e-05 | 199 | 98 | 5 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.83e-05 | 199 | 98 | 5 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.83e-05 | 199 | 98 | 5 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 199 | 98 | 5 | f9e3fb974ba8fe1b6d99892577549ef143df9e08 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.83e-05 | 199 | 98 | 5 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 199 | 98 | 5 | d946db0e8cc3fbed2d0eb9b4346400138d43219f | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.83e-05 | 199 | 98 | 5 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.83e-05 | 199 | 98 | 5 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 7.83e-05 | 199 | 98 | 5 | cea1b30f3e3a9b4ccbc8b57f82352067be1a1d68 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.02e-05 | 200 | 98 | 5 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | critical-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.02e-05 | 200 | 98 | 5 | e2d0e635b70f4bc25e1d374d46e63efbb2e2be0f | |
| ToppCell | cellseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.02e-05 | 200 | 98 | 5 | 6a3020ced89b1d0864f087ecd03be2b86e6bb210 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.02e-05 | 200 | 98 | 5 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | fc73565f973c70915e7415f30d7295a63e33d712 | |
| ToppCell | critical-Epithelial-Secretory-diff|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.02e-05 | 200 | 98 | 5 | 407465404c5818bd2cd9d489bfbf29c3a55429d4 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.02e-05 | 200 | 98 | 5 | 482dfbbd8958b64c31568dccbffe3cc9589f876b | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 111 | 98 | 4 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-04 | 144 | 98 | 4 | ea174487f8ade90deb33b964a7f7e65062606565 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.53e-04 | 152 | 98 | 4 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.71e-04 | 154 | 98 | 4 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.71e-04 | 154 | 98 | 4 | ac539c8ca9e1d48b59bff8026775c2147543f3e2 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-04 | 65 | 98 | 3 | 6e074496433d86c2818e72f18cdbe00eb33333b7 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 3.99e-04 | 157 | 98 | 4 | 6ce7f2ea613e7f8e771860e8c0512274e4f54369 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_TEM|ICU-NoSEP / Disease, Lineage and Cell Type | 4.09e-04 | 158 | 98 | 4 | 8616b308d5c1a1042b23a9aaca971029ba732eb8 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Basal|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.29e-04 | 160 | 98 | 4 | f538ce75500773b5dda53fec4cde2f557d816f4e | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TCM|ICU-NoSEP / Disease, Lineage and Cell Type | 4.29e-04 | 160 | 98 | 4 | a1bf6ed365cbc1ddb57c132a42dbe6485d45f544 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.60e-04 | 163 | 98 | 4 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.82e-04 | 165 | 98 | 4 | 2d01ae5d05fe55f6bebd53a5801c4c1f1544515c | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 4.93e-04 | 166 | 98 | 4 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-04 | 167 | 98 | 4 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 169 | 98 | 4 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | IIF-Lymphocyte-T_NK-Treg|IIF / Disease, Lineage and Cell Type | 5.27e-04 | 169 | 98 | 4 | aac6ff89e0b3bc1f644e6cc6a696360659b254b5 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-04 | 170 | 98 | 4 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-04 | 170 | 98 | 4 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.51e-04 | 171 | 98 | 4 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Deuterosomal|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.63e-04 | 172 | 98 | 4 | 08ad76412c9cc3504141797b44b88478ced87476 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-04 | 172 | 98 | 4 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.63e-04 | 172 | 98 | 4 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-04 | 172 | 98 | 4 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.76e-04 | 173 | 98 | 4 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 173 | 98 | 4 | e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 174 | 98 | 4 | 3b1ee39e85e5f0d6b17fb3051dbfae66cb2be6ee | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 5.88e-04 | 174 | 98 | 4 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 174 | 98 | 4 | cdfc50e5383c8670ce5109736aff36406f46c03d | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-04 | 175 | 98 | 4 | 4be01bf30331162f1998216fb2871a4e626dc440 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.01e-04 | 175 | 98 | 4 | 2fbffcb843f364645b99d1211698d96092abc5ef | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.01e-04 | 175 | 98 | 4 | d0d5ae2a9357aa183ab720c891d86b80c9822930 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-04 | 175 | 98 | 4 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-31|World / Primary Cells by Cluster | 6.01e-04 | 175 | 98 | 4 | 491508bf9e8a09b057d5711cc23dd91324e6a806 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 176 | 98 | 4 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-04 | 176 | 98 | 4 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.27e-04 | 177 | 98 | 4 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.92e-07 | 196 | 99 | 9 | 2174_UP | |
| Drug | lithium sulfate monohydrate | 2.32e-06 | 22 | 99 | 4 | CID000165815 | |
| Drug | NSC406942 | ANXA2 ENPP1 ENPP2 SRP54 AKR1A1 YES1 GJA3 AKR1B10 HPS6 DHODH MCRS1 IFT122 | 6.30e-06 | 565 | 99 | 12 | CID000001115 |
| Disease | azoospermia (implicated_via_orthology) | 1.67e-06 | 27 | 95 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | peroxiredoxin-1 measurement | 3.07e-05 | 3 | 95 | 2 | EFO_0020629 | |
| Disease | gestational age | 8.60e-05 | 138 | 95 | 5 | EFO_0005112 | |
| Disease | margarate 17:0 measurement | 3.64e-04 | 9 | 95 | 2 | EFO_0021066 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 5.54e-04 | 11 | 95 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 9.10e-04 | 14 | 95 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Atherosclerosis | 9.22e-04 | 59 | 95 | 3 | C0004153 | |
| Disease | Atherogenesis | 9.22e-04 | 59 | 95 | 3 | C1563937 | |
| Disease | serum metabolite measurement | TANC2 NAALAD2 CDC42BPA PKD2L1 LDLR OLFML3 ALDH1L2 LINC02902 DNAH17 ALK | 9.37e-04 | 945 | 95 | 10 | EFO_0005653 |
| Disease | response to radiation, Urinary retention | 1.35e-03 | 17 | 95 | 2 | GO_0009314, HP_0000016 | |
| Disease | Eye Abnormalities | 1.35e-03 | 17 | 95 | 2 | C0015393 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.22e-03 | 80 | 95 | 3 | DOID:1459 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKPVNVGALSKWVGK | 291 | O60507 | |
| VGALSKWVGKIPPDV | 296 | O60507 | |
| IQQKLSKLKGEPGWV | 136 | O14727 | |
| WKSLGKPVKPSGVMK | 806 | Q58F21 | |
| GSTEQKKGKFPLWPE | 36 | Q8N7X0 | |
| VVSWILKGKPPGRLD | 56 | Q6ZNB7 | |
| DGTPVFKLPKWRVKG | 71 | Q3SY69 | |
| VGLGTWKSPLGKVKE | 16 | O60218 | |
| SWPESEGKPRVKGSK | 211 | Q99490 | |
| VGWGTPKVTRLPKLE | 381 | Q3SXY8 | |
| AGVKRKGTDVPKWIS | 201 | P07355 | |
| AGVKRKGTDVPKWIS | 201 | A6NMY6 | |
| HLWQGKKPTTPKKGG | 1231 | Q9P1Y5 | |
| CITVGKKPESIPGGW | 531 | P58397 | |
| QGSPKPTISWKKGDR | 506 | O94779 | |
| SGEPGVPTKKTWFDK | 496 | Q5T8P6 | |
| SGLEGPLTKKPWLGK | 566 | Q9P2N5 | |
| KILKRFGGPAGLWTK | 146 | Q9NRN5 | |
| KVKIERPGGSLSPIW | 166 | Q9HBG6 | |
| TSLLGWEKLPKKGFP | 1001 | Q9BXT6 | |
| VWGGGKSTPQKLDVI | 351 | Q8TD19 | |
| KWKKIVLQGGGLESP | 196 | Q9HBU1 | |
| WIEGNPKLSFLKPGI | 646 | O95786 | |
| CGNFLGGKWIPKEKP | 336 | Q12766 | |
| KGGPWKVISLPQALD | 81 | A0A0J9YX94 | |
| KKWVPIKPGQQGFSR | 21 | Q9UI08 | |
| LTWQKGLLKKGPGIC | 326 | Q6ZV70 | |
| VKIWGRKSVGGPKID | 871 | Q8NG31 | |
| HTWGGLLPVISKLKK | 226 | P22413 | |
| GDWEKKKPVPVLLGS | 306 | Q9NX02 | |
| LVKTKLGWPAGVTLD | 551 | P98164 | |
| GQGKKEKTLVVNPWL | 4301 | P98164 | |
| PGEGLGIFSKTWIKA | 96 | Q9H4Q4 | |
| HVKVPKPTGVKKGWQ | 1101 | Q9Y5S2 | |
| GRKTNIWTIIPKKLG | 841 | Q6IE36 | |
| TKGGKIPNPIRSWKD | 381 | Q9BUQ8 | |
| IPLGSLGWKTVKQPV | 226 | Q16795 | |
| VKTKRGPLGPNWKKE | 166 | P48739 | |
| GNPKPSVIWSKKGEL | 1006 | Q96RW7 | |
| KGTPKPTIKWLHNGR | 1291 | Q96RW7 | |
| KGDLWGPGLSPKEVK | 2671 | Q96RW7 | |
| NGIPTPLIQWLKDGK | 3271 | Q96RW7 | |
| PLIQWLKDGKPIASG | 3276 | Q96RW7 | |
| GWKPGSDTIKPDVQK | 176 | Q06830 | |
| ATGDPKPRVTWNKKG | 56 | Q13332 | |
| PPGGVTKWKSDVALN | 251 | Q5T0Z8 | |
| SPKAWLGPGTAKLLK | 411 | Q8IV32 | |
| IKWVDGGKPLLKIST | 801 | Q9BZ29 | |
| KKGKLQKEAGTPPLW | 181 | P55265 | |
| LTAPGGKIPKDKSWK | 3171 | Q9UFH2 | |
| LPLEGWSPALKTQGK | 966 | Q8N1P7 | |
| AWILIVSCKKGKGTP | 131 | Q6ZTY9 | |
| EGKNIIIWLPTGAGK | 16 | Q96C10 | |
| VINKVFKDWKPGGVI | 596 | Q96C10 | |
| KKGGKNISPVVFQLW | 406 | Q6ZN28 | |
| EGPAWKISRKQGVIK | 381 | Q96EZ8 | |
| GQIKGLTSWPGKLVR | 1391 | Q9P267 | |
| PWEVLKRKPKDAGGG | 256 | P35367 | |
| TVKGKGCPKPIKSWV | 361 | Q7L014 | |
| GWKKLKQGVTSRLGP | 226 | Q9Y6H8 | |
| PDVWKKVLGGITAGK | 541 | Q86YV9 | |
| EAKWVPGVPGNTKII | 766 | Q68D06 | |
| PGGQKSPSKWFWKLV | 211 | Q08AD1 | |
| GGQPLWITATKQGVK | 256 | Q13822 | |
| ATGEPKPRITWMKKG | 56 | P10586 | |
| TWGKNKPGIGAVILK | 511 | Q9Y2M0 | |
| GAKQNTGVWLVKVPK | 11 | P13984 | |
| GGKPNKTRVIWGKVT | 61 | P18077 | |
| AGSSGENKKAKPVPW | 26 | P35249 | |
| LVDPGVKAWTPTKGK | 86 | P61011 | |
| LIDKKWKPLQGVGNL | 1221 | P30414 | |
| TALTFWGPPVVGKVK | 356 | Q02127 | |
| GPLTESWKDGNPLKK | 416 | Q9NYZ4 | |
| VTLLKKGAKIGPATW | 1216 | Q9HCD6 | |
| GDWEKKKPVPVLLGS | 271 | Q8WX94 | |
| IKQGGPSAGKWVELP | 561 | O75592 | |
| LAKKDGGPWPTRKAQ | 1136 | Q5T8A7 | |
| FVIGKGNKPWISLPR | 226 | P62701 | |
| IPKPAGVKKGWQRAL | 1091 | Q5VT25 | |
| SNGPVKVWGSIKGLT | 26 | P00441 | |
| NWPKQKAVTGLVGIG | 821 | P63128 | |
| SEGPLKGIQIWKVPA | 716 | Q9UM73 | |
| LIGLGTWKSEPGQVK | 16 | P14550 | |
| IWKKLFVPLKAGGAP | 41 | Q3C1V1 | |
| GLGWRPKVPWKEGIK | 311 | O95455 | |
| SGVLVLDPTSGPKWK | 731 | O95985 | |
| LVGGKPTGKWQLKVS | 1006 | Q8N2E2 | |
| KNWPKQKAVTGLVGI | 41 | P63127 | |
| KNWPKQKAVTGLVGI | 41 | P63129 | |
| KPKKPLTLSLHGWTG | 91 | O14656 | |
| GPIPAIKQAVTKAGW | 296 | Q9BWD1 | |
| PGVRGSWKKKAPNKA | 191 | P98077 | |
| KNWPKQKAVTGLVGI | 41 | P63121 | |
| KPAVSGKQGNVLPLW | 36 | Q5VTL8 | |
| AELWTGIKKGPPRKL | 91 | Q8IZQ5 | |
| KNWPKQKAVTGLVGI | 41 | P63131 | |
| KWSSKPGIPAAEVGI | 911 | P18206 | |
| KNWPKQKAVTGLVGI | 41 | Q9Y6I0 | |
| KNWPKQKAVTGLVGV | 41 | P63125 | |
| GKKRKWGGTVVAEPQ | 1741 | O43151 | |
| KNWPKQKAVTGLVGI | 41 | P10265 | |
| KGWLAPSPGVKEQAI | 741 | Q9P0L9 | |
| QLSPEKSEIWGPGLK | 26 | Q6UW63 | |
| QIKEGKPSWGLPIDA | 371 | Q9BV44 | |
| KNWPKQKTVTGLVGI | 41 | P63123 | |
| MTWNSRKLKGKLPPG | 316 | Q502W6 | |
| KNWPKQKAVIGLVGI | 41 | P63122 | |
| QKWIVKPPASARGIG | 716 | Q14679 | |
| ISKLEKGEAPWLGKG | 81 | Q9Y6Q3 | |
| KNWPKQKAVTGLVGI | 41 | P63119 | |
| FVVLPWGKPGNSVKL | 6 | A8MT70 | |
| DKKKFWLIPIGSSPG | 276 | Q96MV8 | |
| KNWPKQKAVTGLVGI | 41 | P63124 | |
| WNGTTKVAIKTLKPG | 296 | P07947 | |
| KNWPKQKAVTGLVGI | 41 | P63120 | |
| PGKLPVTTWEKGKGS | 4766 | O14686 | |
| WGTPAKIKKGGLNGV | 536 | P01130 | |
| GIAPPDKSWKGALNV | 301 | Q9Y3Q0 | |
| KGIGWIPIGSLDVEK | 1201 | P20929 |